Delivery Order SPE2DB24D2205-SPE2DB25FEEAJ
Award Date 6/24/25
Potential Completion Date 7/16/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,440.40, is for the delivery of XOLAIR 150 MG/ML syringes. It is a firm fixed-price contract with a completion date of June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,923.80 firm-fixed-price contract is for the delivery of XOLAIR 150 MG/ML SYRINGE, a medication, with a completion date of August 7, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.36 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a performance period through July 18, 2025. The contract is a firm fixed-price delivery order, not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGE/ML. The $2,532.12 firm fixed-price contract has a June 3, 2025 completion date and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- This is a $2,161.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply XOLAIR 150 MG/ML SYRINGEML. The contract has an ultimate completion date of August 6, 2025 and was not set aside for any specific business size or type. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,393.14 firm-fixed-price contract is for the delivery of XOLAIR 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period through August 1, 2025. Amerisourcebergen Drug Corp is the prime contractor and the contract is not set-aside. The company holds a larger $999,999,999.00 Indefinite...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $34,576.32 firm fixed price contract is for the supply of XOLAIR 150 MG/ML SYRINGE/ML, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $5,064.24 and a performance period ending on May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a ceiling value of $4,322.04 and a period of performance through July 2, 2025. The contract is a firm fixed-price Delivery Order, indicating a pre-established agreement where task orders can be placed as needed....
- This is a $21,610.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on July 18, 2025. The contract is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...